| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | ||||||||||||||||||||||
| FDA Comment Number : | EC3657 | ||||||||||||||||||||||
| Submitter : | Mr. Pavel Tikhonov | Date & Time: | 12/19/2006 09:12:10 | ||||||||||||||||||||
| Organization : | Mr. Pavel Tikhonov | ||||||||||||||||||||||
| Category : | Individual Consumer | ||||||||||||||||||||||
| Issue Areas/Comments | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| GENERAL | |||||||||||||||||||||||
| We, Pavel M. Tikhonov from the Russian Fedration and his family, are very much concerned with ethical issues regarding the use of aborted fetal cell lines by
vaccine manufacturers around the world. Some of such vaccines are imported by the Russian Government, from the USA as well (MMR II, Vaqta 25 & Vaqta 50). We are facing freedom of conscience violation when are trying to escape morally objectionable vaccine sources. Many people (including us) are ready to take health risks and other trouble just to escape from taking vaccines derived from aborted fetal cells. We think that both manufacturers and consumers will benefit from the use of non-objectionable sources. We ask you to promote the use of non-objectionable materials and cell substrates in vaccines. We know many russian families who cannot write a comment in English but share the same concerns. We also request for fair labeling of vaccines to indicate their contents for the consumers to make informed decisions. The current regulatory requirements for labeling do not give adequate information to the consumer on whether human embryos, human embryonic stem cells or materials derived from embryos or stem cells are used in the manufacture or testing of pharmaceuticals or not. We call everyone who regulate the vaccine manufacturing or pharmaceutical industry for help. Best regards, Pavel M. Tikhonov, Anna V. Tikhonova. | |||||||||||||||||||||||